Viral Hepatitis
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 4013-4017
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4013
Table 5 Comparison of NYT and other drugs which were reported to be effective for RBV-induced anemia
ActionMechanismsIndication for anemia in healthFormAdverse reactionsDaily cost
insurance system of Japan(yen)
NYTPromotion of erythropoiesis,Activation of immatureAnemia inGranuleAbdominal discomfort227.7
protection of erythrocyticerythroid cells,general,(frequency unknown)
membrane, improvement ofantioxidant effect
erythrocytic deformability
EPAIncrease in erythrocyteIncrease in EPA content inNoneCapsuleJaundice, gynecomastia353.4
deformabilityerythrocytic membrane(frequency unknown),
phospholipidshemorrhagic tendency,
liver injury (< 0.1%)
EPOIncrease in erythropoiesisStimulation of stem cellRenal anemiaVial forThromboembolism,1643
differentiation toinjectioncerebral hemorrhage,(750 IU)
erythroid cellsshock (frequency unknown),
high blood pressure, liver
injury (0.1-< 5%)